Sitagliptin
Gentle once-daily diabetes tablet with low hypo risk.
- Starts working
- Varies
- Half-life
- About 12 hours
- In use since
- 2006
- Pregnancy
- Usually avoided
Overview
Sitagliptin was the first DPP-4 inhibitor ('gliptin'). It modestly lowers blood sugar, doesn't cause weight gain or hypos on its own and is easy to take. Generic versions transformed prices in India after 2022.
Conditions it's used for
How it works
Boosts gut hormones that release insulin after meals.
Sitagliptin belongs to the DPP-4 inhibitors. How DPP-4 inhibitors work: stop an enzyme breaking down incretin hormones, so more insulin is released after meals.
Uses
- Type 2 diabetes
Available as: tablet, combination tablets with metformin.
Typical dose
- Adults
- 100 mg once a day (50 or 25 mg with kidney disease).
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Headache
- Cold symptoms
- Joint pain
Serious — get medical help
Uncommon, but need prompt attention
- Pancreatitis (severe stomach pain)
- Blistering skin condition (bullous pemphigoid, rare)
Warnings
- Stop and seek help for severe, persistent stomach pain
Who should avoid it
- History of pancreatitis (caution)
- Allergy to sitagliptin
- Type 1 diabetes or ketoacidosis
Interactions
- Sulfonylureas and insulin — hypos when combined
Using it safely
- Alcohol
- Best to limit. Heavy alcohol use raises the risk of pancreatitis.
- Food and drink
- With or without food.
- If you miss a dose
- Take it when you remember the same day; skip if next dose is near.
- Stopping it
- Can be stopped; blood sugar may rise.
- Driving
- No effect.
- Tests and checks
- HbA1c; eGFR; Signs of pancreatitis
- If too much is taken
- Usually well tolerated; seek advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
Not recommended; insulin preferred.
Breastfeeding
Usually avoided
Avoid; limited data.
Special groups
- Kidney disease
- Reduce the dose in moderate to severe impairment.
- Liver disease
- No adjustment.
- Older adults
- Adjust for kidney function.
Brand names
- United States
- Januvia, Janumet (with metformin)
- United Kingdom
- Januvia
- India
- Januvia, Istavel, Zita
- Australia
- Januvia
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Is it weight-neutral?
Yes — on average it doesn't change weight.
Do I need a prescription for Sitagliptin?
Yes — Sitagliptin is prescription-only in most countries.
Can I take Sitagliptin during pregnancy?
Usually avoided. Not recommended; insulin preferred. Always check with a doctor or midwife.
Related medicines
Metformin
First-choice tablet for type 2 diabetes.
RxWHOBiguanidesEmpagliflozin
Diabetes tablet that also protects heart and kidneys.
RxSGLT2 inhibitorsLinagliptin
Once-daily diabetes tablet with a low hypo risk on its own.
RxDPP-4 inhibitorsGliclazide
Sulfonylurea that boosts insulin release.
RxWHOSulfonylureasDapagliflozin
SGLT2 inhibitor for diabetes, heart failure and kidney disease.
RxSGLT2 inhibitorsTeneligliptin
Low-cost DPP-4 inhibitor used in India and Japan.
RxDPP-4 inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — A10BH01
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.